Search by Drug Name or NDC

    NDC 00781-5514-05 Griseofulvin 250 mg/1 Details

    Griseofulvin 250 mg/1

    Griseofulvin is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is GRISEOFULVIN.

    Product Information

    NDC 00781-5514
    Product ID 0781-5514_d4ebe202-2232-4415-82ad-e73488b09757
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Griseofulvin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Griseofulvin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name GRISEOFULVIN
    Labeler Name Sandoz Inc
    Pharmaceutical Class Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091592
    Listing Certified Through 2024-12-31

    Package

    NDC 00781-5514-05 (00781551405)

    NDC Package Code 0781-5514-05
    Billing NDC 00781551405
    Package 500 TABLET in 1 BOTTLE (0781-5514-05)
    Marketing Start Date 2013-08-07
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 98829d90-b289-4bec-a625-7af412a5cb2d Details

    Revised: 12/2016